Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Disruptive Pharma AB
AB
Active
Org 5591746085
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Disruptive Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
DP
Dan Peter Åsberg
Chief Executive Officer
Chief Executive Officer
2021
JE
Johan Erik Niclas Bergenmo
Chief Auditor
Chief Auditor
2022
Former (1)
EM
Eva Maria Andersson Dverstorp
Chief Auditor
Chief Auditor
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DP
Dan Peter Åsberg
Board of Directors
Board of Directors
2021
PS
Per Stefan Ström
Deputy Board Member
Deputy Board Member
2021
Former (2)
OH
Oskar Henrik Gauther Lund
Deputy Board Member
Deputy Board Member
2021 – 2021
LM
Lars-Erik Mattias Karls
Board of Directors
Board of Directors
2021 – 2021
Shareholders
As of last annual report
Disruptive Pharma Holding AB (publ) — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Disruptive Pharma Holding AB (publ)
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Disruptive Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network